Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the Modified Mayo Score at Week 12, and that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the M
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this ulcerative colitis clinical trial in Los Angeles, CA
If you're searching for ulcerative colitis treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.